0001415889-22-011244.txt : 20221109 0001415889-22-011244.hdr.sgml : 20221109 20221109163106 ACCESSION NUMBER: 0001415889-22-011244 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20221107 FILED AS OF DATE: 20221109 DATE AS OF CHANGE: 20221109 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EDGEMOND JAMES CENTRAL INDEX KEY: 0001636178 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-26301 FILM NUMBER: 221373167 MAIL ADDRESS: STREET 1: 1040 SPRING STREET CITY: SILVER SPRING STATE: MD ZIP: 20910 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: UNITED THERAPEUTICS Corp CENTRAL INDEX KEY: 0001082554 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 521984749 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 BUSINESS PHONE: 3016089292 MAIL ADDRESS: STREET 1: 1040 SPRING ST CITY: SILVER SPRING STATE: MD ZIP: 20910 FORMER COMPANY: FORMER CONFORMED NAME: UNITED THERAPEUTICS CORP DATE OF NAME CHANGE: 19990324 4 1 form4-11092022_041154.xml X0306 4 2022-11-07 0001082554 UNITED THERAPEUTICS Corp UTHR 0001636178 EDGEMOND JAMES C/O UNITED THERAPEUTICS CORPORATION 1040 SPRING STREET SILVER SPRING MD 20910 false true false false CFO AND TREASURER Common Stock 2022-11-07 4 M 0 5000 52.12 A 6384 D Common Stock 2022-11-07 4 D 0 5000 266.80 D 1384 D Common Stock 2022-11-07 4 M 0 2411 94.96 A 3795 D Common Stock 2022-11-07 4 D 0 2411 266.80 D 1384 D Share Tracking Award 52.12 2022-11-07 4 M 0 5000 0 D 2015-02-28 2023-01-14 Share Tracking Award 5000 0 D Share Tracking Award 94.96 2022-11-07 4 M 0 2411 0 D 2015-03-14 2024-03-14 Share Tracking Award 2411 0 D Exercise of a share tracking award by the reporting person. Share tracking awards are non-dilutive, cash-settled stock appreciation rights, which may only be settled in cash and may not be converted into shares of common stock. Includes 23 shares acquired on September 4, 2019, 297 shares acquired on March 4, 2020, 156 shares acquired on March 4, 2021, 58 shares acquired on September 3, 2021, 97 shares acquired on March 4, 2022 and 26 shares acquired on September 2, 2022, under the United Therapeutics Corporation Employee Stock Purchase Plan. /s/ John S. Hess, Jr. under Power of Attorney 2022-11-09